BAX vs IART
BAX: Baxter International is a leading medical technology company delivering critical life-sustaining therapies for patients with complex medical conditions in hospitals and at home. IART: A global medical technology firm specializing in innovative surgical instrumentation, neurosurgical devices, and regenerative tissue repair solutions.
Side-by-side fundamentals
| Metric | BAX | IART | Edge |
|---|---|---|---|
| Price as of 2026-07-31 close | $26.16 | $19.53 | |
| Market cap as of 2026-08-03 | $13.5B | $1.5B | |
| PEG as of 2026-08-03 | -0.02 | 1.40 | BAX lower |
| Net margin as of 2026-08-03 | -9.3% | -30.1% | BAX higher |
| Gross margin as of 2026-08-03 | +30.6% | +57.1% | IART higher |
| Operating margin as of 2026-08-03 | -2.3% | -28.4% | BAX higher |
| ROE as of 2026-08-03 | -16.4% | -47.6% | BAX higher |
| ROA as of 2026-08-03 | -5.4% | -13.7% | BAX higher |
| Debt / equity as of 2026-08-03 | 1.57 | 1.79 | BAX lower |
| Revenue growth (YoY) as of 2026-08-03 | +5.4% | +1.2% | BAX higher |
| Revenue CAGR (3y) SEC XBRL | +3.8% | +1.6% | BAX higher |
| Dividend yield as of 2026-08-03 | +0.2% | n/a | |
| Dividend streak (yrs) SEC XBRL | 1 | n/a | |
| Beta as of 2026-08-03 | 0.87 | 1.22 | |
| 1-year return as of 2026-07-31 close | +20.2% | +49.0% | IART higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-31.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.